The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome.
about
Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: Part II - contemporary contextual researchRifaximin for Irritable Bowel Syndrome: A Meta-Analysis of Randomized Placebo-Controlled TrialsObesity as a consequence of gut bacteria and diet interactionsAcne vulgaris, probiotics and the gut-brain-skin axis: from anecdote to translational medicineDisruption of the human gut microbiota following Norovirus infectionSmall Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic DichotomyThe microbiota-gut-brain axis in functional gastrointestinal disorders.A role for the gut microbiota in IBS.Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model.Comparison of the antibacterial activity of essential oils and extracts of medicinal and culinary herbs to investigate potential new treatments for irritable bowel syndrome.The impact of proton pump inhibitors on the human gastrointestinal microbiomeAntibiotics for irritable bowel syndrome: rationale and current evidence.Small bowel bacterial overgrowth in patients with irritable bowel syndrome: the first study in iranOvergrowth of the indigenous gut microbiome and irritable bowel syndrome.Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets.Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome.Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects.Role of the Gut Microbiome in Obesity and Diabetes Mellitus.Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea.Rifaximin for the treatment of irritable bowel syndrome - a drug safety evaluation.Small intestinal bacterial overgrowth is associated with irritable bowel syndrome and is independent of proton pump inhibitor usage.Small Intestinal Bacterial Overgrowth in Patients with Refractory Functional Gastrointestinal Disorders.Lactulose Hydrogen Breath Test Result Is Associated with Age and GenderThe Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease.Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortalityThe use of non-narcotic pain medication in pediatric gastroenterology.Irritable Bowel Syndrome and the Small Intestinal Microflora. What Do We Know?Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth.Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.How to Test and Treat Small Intestinal Bacterial Overgrowth: an Evidence-Based Approach.Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link.Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test.Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus.Draft Genome Sequence of Enterococcus sp. Strain HSIEG1, Isolated from the Human Small Intestine.Commentary: associations between immune activation, intestinal permeability and irritable bowel syndrome.A definitive blood test for post-infectious irritable bowel syndrome?Aciduric Strains of Lactobacillus reuteri and Lactobacillus rhamnosus, Isolated from Human Feces, Have Strong Adhesion and Aggregation Properties.Gut Microbiota-Based Therapies for Irritable Bowel Syndrome.Antibiotic treatment of constipation-predominant irritable bowel syndrome.
P2860
Q21198786-AE16CACB-6053-4907-BF36-9C3CF95B15CDQ26772962-EE522A58-4D41-4895-ACC1-C565275C4841Q27001257-A98903E4-6127-4482-87D7-B5ABFE9C1BAEQ28295293-1F57954B-6A4E-48D2-BA8E-DE7CF9E308E1Q30424368-BEE7B2D8-0C5F-43F8-ABAF-64FECAC05AF2Q33469991-D2E832CB-4D4B-4CCD-BE30-20F39571DF7CQ34129427-E484654E-B5D6-4A67-8C37-BFD9EB06A599Q34416297-BAA2D97E-CE6A-4267-B26C-B856996F905DQ34449503-40C32906-37E2-4FF1-B9D9-C5F6E9EE362CQ34454007-9C604291-CA2D-49BF-8060-C06585C6749AQ34625008-58E882FF-DA37-4788-9620-96E2CEA7DB7BQ34642080-B5AB4344-C6EB-4E65-81BD-DA149749B8DAQ34950787-4F03835C-8F20-4920-87E2-3222B6486BB8Q35120395-E7EDF9FC-C675-4A64-AB7C-CF3132C387D3Q35130485-C8A27E9F-3837-4D9C-8B5B-84CB0235EAF9Q35599906-448E5F9C-C1ED-4892-8EF5-51AD7879A5A7Q35603014-4616E9AA-F2A6-4B04-BBBD-ECEC5EF19AE1Q35801939-0DEA6FCB-3792-4C48-8C18-908982C9F60FQ35855740-E2736C28-87D3-4707-A7EA-4CC469F575C0Q36009729-E86410A7-848C-4C3B-AE61-BDD869928938Q36073385-A1016A83-0649-4214-A11D-84602DF70640Q36426034-87925397-FE58-47B4-8727-837183776884Q36747480-6DA326C2-C1AD-4D9B-867F-2DAC30DD6D5CQ36751990-54131446-828D-4231-8258-6D6E346EF403Q37113096-752C0471-36EE-422F-A71C-2C287B866629Q38221358-11009429-60DE-404A-B52B-431247A282FFQ38528094-47DB5BF4-6276-42F9-A202-FF13BDC4D455Q38645247-ECC98952-9585-4928-B574-7896FD4F6939Q38692607-6C7894B0-64BF-4972-AC4D-420040FF5C5FQ38701265-7A976443-D6CB-4E60-A2D2-74C7694BB7ABQ38988993-9E6E97B8-1BBE-426D-B000-C1A426DC50FDQ39022623-D467DD59-16EB-4575-9940-ACC35222BBE4Q41534928-6285937C-4788-4460-A8A5-0AB4EADC800CQ42289564-8BB5F96F-3A73-4FD0-924E-3694C2BB2E5CQ42802514-B2D4FAA0-CCD4-406A-B01D-429E744FACEDQ45912540-34CE9CA6-3636-4B26-8A9E-37882F1B61CCQ46484371-E5A3FF8A-F3E0-4416-86C2-8CBDEE5F69D4Q46971057-F126B2D8-A9A2-4980-B85C-8C0ED3ABA492Q49985626-02A2C9E9-63DE-412B-A1D3-E44A3FFA3628Q51726426-9579654C-0FA6-4C20-8ABE-F6511BA12551
P2860
The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The prevalence of overgrowth b ...... with irritable bowel syndrome.
@ast
The prevalence of overgrowth b ...... with irritable bowel syndrome.
@en
The prevalence of overgrowth b ...... with irritable bowel syndrome.
@nl
type
label
The prevalence of overgrowth b ...... with irritable bowel syndrome.
@ast
The prevalence of overgrowth b ...... with irritable bowel syndrome.
@en
The prevalence of overgrowth b ...... with irritable bowel syndrome.
@nl
prefLabel
The prevalence of overgrowth b ...... with irritable bowel syndrome.
@ast
The prevalence of overgrowth b ...... with irritable bowel syndrome.
@en
The prevalence of overgrowth b ...... with irritable bowel syndrome.
@nl
P2093
P2860
P1476
The prevalence of overgrowth b ...... with irritable bowel syndrome.
@en
P2093
Charalambos Barbatzas
Dimitrios Tzivras
Emmannouil Pyleris
Evangelos J Giamarellos-Bourboulis
Vassilios Koussoulas
P2860
P2888
P304
P356
10.1007/S10620-012-2033-7
P577
2012-01-20T00:00:00Z
P5875
P6179
1022361939